University of Michigan Selects Dr. David Miller as New CEO for Michigan Medicine in 2025

Dr. David Miller, the current chief clinical officer for University Hospital and the incoming president of the University of Michigan Health System, has been chosen as the new CEO for Michigan Medicine, set to take over in 2025. The decision comes as the current CEO is stepping down next year. Dr. Miller will also serve as the university's executive vice president for medical affairs, a move approved by the university Board of Regents during its Sept. 19 meeting. Michigan Medicine continues to be at the forefront of healthcare innovation and leadership, with this upcoming transition marking a new chapter in its esteemed history.
Exciting Leadership Change Ahead
The University of Michigan announced a significant leadership change with the selection of Dr. David Miller as the new CEO for Michigan Medicine starting in 2025.
Experience and Expertise
Dr. Miller, who currently holds the position of chief clinical officer for University Hospital, is well-known for his dedication to patient care and medical excellence.
Future Vision and Direction
As the incoming president of the University of Michigan Health System, Dr. Miller is poised to lead Michigan Medicine towards a promising future filled with advancements in healthcare research, education, and patient care.
University Approval
The decision to appoint Dr. Miller as the new CEO and executive vice president for medical affairs was officially approved by the university Board of Regents during a recent meeting, highlighting the trust and confidence in his leadership abilities. This strategic move is expected to further enhance Michigan Medicine's reputation as a premier healthcare institution. In conclusion, Dr. David Miller's appointment as the new CEO for Michigan Medicine sets the stage for a bright future ahead, building on the foundation of excellence and innovation that the institution is known for.